Skip to main content
Equibles

INNPF · INNOCAN PHARMA Corp · Analyst Estimates

Track INNPF — free

Use INNPF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INNPF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.29 -0.01 (-0.77%) At close · Oct 26
Rebalance outlook locked
Market Cap
$5.80M
Shares
4.50M
Volume · Oct 26 100 Avg daily vol (15 sessions) 161

Analyst Estimates

Compare analyst forecasts for INNOCAN PHARMA Corp across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Published by the company

No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.

No published consensus found

No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.

Key facts CIK 1889791 CUSIP 45783P508 Visit website Investor relations